Top Industry News

The latest news on mergers and acquisitions featuring Sanofi/Dren Bio, Eli Lilly and Company/SiteOne Therapeutics, AstraZeneca/EsoBiotec, Sanofi/Vigil Neuroscience, BioMarin/Inozyme Pharma and TQ Therapeutics/Bristol-Myers Squibb/Juno Therapeutics. Highlights below.  * Sanofi Completes…

Roche has announced plans to invest more than $700 million in a new 700,000-square-foot drug manufacturing facility in Holly Springs, North Carolina. Additionally, Roche has announced plans to build a…

Sanofi has announced its intention to invest at least $20 billion in the US through 2030.  Although not detailing specifics, the company says that “the expected investment includes a significant increase…

The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma, Famar Group, Recipharm/ProductLife Group and Ecolab Life Sciences.   Biologics Manufacturing * Ecolab Opens New Bioprocessing Lab Formulation Development/Drug Product Manufacturing * Famar To…

The latest news on mergers and acquisitions featuring GSK/Boston Pharmaceuticals and bluebird bio/Carlyle/SK Capital Partners. Highlights below.  * GSK To Acquire Liver Disease Drug from Boston Pharmaceuticals in $2-Bn Deal*…

A roundup of bio/pharmaceutical partnering news from Novo Nordisk/Septerna, AbbVie/ADARx Pharmaceuticals, and Eli Lilly and Company/Purdue University.  * Novo Nordisk, Septerna in $2.2-Bn Small-Molecule Cardiometabolic Drug Pact* AbbVie, ADARx Pharmaceuticals…

Gilead Sciences has announced an additional $11 billion in capital and operational investments in the US to supplement an already planned spend of $21 billion in US manufacturing and R&D…

The European Commission has taken two additional steps in response to potential tariffs by the US as it negotiates a possible trade deal with the US. This week (May 7,…

The US Food and Drug Administration (FDA) Commissioner, Dr. Martin Makary, reports that FDA has completed its first pilot using artificial intelligence (AI) in the agency’s scientific review process and…

The US Food and Drug Administration’s (FDA) Commissioner, Dr. Martin Makary, has named  Vinay Prasad, M.D., M.P.H., a hematologist–oncologist, who most recently served as Professor in the Department of Epidemiology…